Grading and Staging of Tumors

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 11

Grading and Staging of

Tumors
DR ALIYA ZAMAN
Grading
Tumor grade is the description of a tumor based on how
abnormal the tumor cells and the tumor tissue look under a
microscope.
The degree of differentiation of the tumor cells
It is an indicator of how quickly a tumor is likely to grow
and spread
 “well-differentiated .” These tumors tend to grow and
spread at a slower rate
 “undifferentiated” or “poorly differentiated,” which have
abnormal-looking cells and may lack normal tissue
structures
How is tumor grade determined?
If a tumor is suspected to be malignant, a doctor
removes all or part of it during a procedure called a 
biopsy.
A pathologist (a doctor who identifies diseases by
studying cells and tissues under a microscope) then
examines the biopsied tissue to determine whether the
tumor is benign or malignant.

The pathologist also determines the tumor’s grade and


identifies other characteristics of the tumor.
If a grading system for a tumor type is not
specified, the following system is generally used
GX: Grade cannot be assessed (undetermined grade)

G1: Well differentiated (low grade)

G2: Moderately differentiated (intermediate grade)

G3: Poorly differentiated (high grade)

G4: Undifferentiated (high grade)
STAGING
The staging of solid cancers is based on

the size of the primary lesion,


its extent of spread to regional lymph nodes
 the presence or absence of blood borne metastases

 The major staging system currently in use is the


American Joint Committee on Cancer Staging (TNM )
system
 American Joint Committee on Cancer
(AJCC) TNM system. 
has both clinical and pathologic staging systems for
breast cancer
The pathologic stage (also called the surgical stage)
is determined by examining tissue removed during an
operation.
If surgery is not possible right away or at all, the cancer
will be given a clinical stage instead. This is based on
the results of a physical exam, biopsy, and imaging
tests. The clinical stage is used to help plan treatment.
TNM STAGING
T for primary tumor
N for regional lymph node involvement
M for metastases.
TNM staging varies for specific forms of cancer, but there are general
principles.
 The primary lesion is characterized as T1 to T4 based on increasing size.
 T0 is used to indicate an in situ lesion.
 N0 would mean no nodal involvement
 N1 to N3 would denote involvement of an increasing number and range
of nodes.
 M0 signifies no distant metastases,
 whereas M1 or sometimes M2 indicates the presence of metastases and
some judgment as to their number.

You might also like